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A juxtaglomerular cell tumor (JGCT) is a very rare cause of
hypertension that was first described by Robertson et al [1].
Patients have hypertension, hyperaldosteronism, and hy-
pokalemia secondary to tumor renin secretion [2], and the
hypertension usually returns to normal immediately or
gradually after tumor removal. Here, we report a case of
JGCT of the kidney with serious cardiovascular complica-
tions that was misdiagnosed for nearly 10 years.
A 62-year-old female was admitted to the Department of
Cardiovascular Surgery at our hospital with severe hyper-
tension, hypertensive heart disease, and pulmonary infec-
tion. She had persistent high blood pressure (BP;
180 110 mmHg, grade III hypertension) with a personal
history of elevated BP for almost 10 years. She took over-
the-counter captopril following diagnosis of hypertension
10 years ago, but she was unable to detail drug dosage or
how well it controlled her BP. Doppler echocardiography
showed left atrium and ventricle hypertrophy, and theFigure 1. (A) Contrast-enhanced computed tomography image
enhanced mass near to the renal hilum of the right kidney. (B) Hema
sheets of uniform round-to-polygonal cells, which had centrally
magnification: 100). (C) Immunoperoxidase staining indicated CD
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Abdominal ultrasound showed 4.7 cm 3.6 cm mixed solid
and cystic lesions in the right kidney. Contrast-enhanced
computed tomography showed a solitary 2.8-cm diameter
low-to-moderate contrast-enhancement mass near to the
renal hilum of the right kidney (Figure 1A). Laboratory tests
showed serum potassium levels at 3.4 mmol/L.
After controlling the BP, the patient was transferred to our
department, where she received a retroperitoneal laparo-
scopic radical nephrectomy. Histological examination of the
tumor showed that it consisted of sheets of uniform round-to-
polygonal cells,whichhadcentrally locatednuclei andslightly
eosinophilic cytoplasm (Figure 2B). Immunohistochemical
study revealed diffuse staining with CD34, vimentin, smooth-
muscle actin (focally), actin (sporadic), and Ki67 (5%;
Figure 1C). Cellswerenegative for all other antibodies tested,
including CK7, RCC, CD10, WT-1, CD57, desmin, CK, LcA, and
HMB45. Histological confirmation was essential to distinguish
JGCT from other kidney carcinomas. For JGCT, immunohis-
tochemical stains for renin, actin, vimentin, and CD34 areof a a solitary 2.8-cm diameter, low-to-moderate contrast-
toxylin and eosin staining indicated that the tumor consisted of
located nuclei and slightly eosinophilic cytoplasm (original
34 reactivity (CD34 antibody; original magnification: 100).
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Letter to the Editor 277usually positive [2]. After surgery, theBPnormalizedwithin 18
months (BP< 140 90mmHg) without any anti-hypertension
medications, and plasma renin activity, aldosterone, and
serum potassium were within normal ranges. We confirmed
that the hypertension was caused by JGCT.
JGCT is a rare, benign, renal neoplasm causing renin-
mediated hypertension [2] that originates from modified
smooth muscle cells from the afferent arteriole of the
juxtaglomerular apparatus [3]. Hypertension due to a
renin-secreting JGCT is mainly seen in adolescents or young
adults and is twice as common in women as men. Most
patients have very high BP, with 17% reporting retinopathic
malignant-phase hypertension [4]. Our patient had experi-
enced headaches and dizziness over a 10-year history of
hypertension, which was also misdiagnosed during this
period.
Here, we reported a case of JGCT of the kidney with
serious cardiovascular complications due to late diagnosis.
JGCT of the kidney should be considered in patients with
hypertension and renal tumors. We must also stay alert to
this disease when hypertension is diagnosed. Moreover,
when curative treatments are unavailable, early recognition
and management may prevent target-organ damage, reduce
socioeconomic burden, and improve quality of life [5].
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